MedTrace Logo

International Severe CRSwNP Registry 2024-2028

NCT06617754 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-04-08

No results posted yet for this study

Summary

The objective of the study is to collect real-life data worldwide, which already have been collected in national databases, to merge the data and the knowledge with the focus of better care for the individual patients, more efficient use of the hospital cost of biologics and working for "personalized medicine".

Conditions

  • Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Interventions

BIOLOGICAL

Biologic drugs

Biologic drugs including Mepolizumab, Dupilumab, Omalizumab, Tezepelumab, or future monoclonal antibodies

Sponsors & Collaborators

  • The European Forum for Research and Education in Allergy and Airway Diseases

    collaborator OTHER

  • Vibeke Backer

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-31
Primary Completion
2030-01-31
Completion
2032-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06617754 on ClinicalTrials.gov